primary NSCLC tissues; adjacent normal lung tissues; lung tissue specimens
A549; H1299; H1650; PC-9; HBE
cell line-derived xenograft
TGF-beta/SMAD (promotes); EMT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); apoptosis (inhibits); ceRNA regulation (other)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; RT-qPCR; Microarray; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Transfection; MTT; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model; ROC Analysis; Bioinformatics Analysis
hsa_circ_0088036 may serve as a diagnostic biomarker and therapeutic target; its expression correlated with tumor size and TNM stage and predicted poor prognosis of NSCLC patients.
hsa_circ_0088036 is upregulated in NSCLC tissues and cell lines and is associated with tumor size, TNM stage, diagnostic value, and poor prognosis. Functionally, it promotes proliferation, migration, invasion, EMT, and xenograft tumor growth while inhibiting apoptosis. Mechanistically, it acts as a ceRNA sponge for miR-1343-3p, upregulates Bcl-3, and activates the TGFbeta/Smad3/EMT signaling pathway.
0.8508
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFbeta/Smad3/EMT signaling.
combined biological and clinical study